Literature DB >> 34223909

Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro.

Marek Widera1, Alexander Wilhelm1, Sebastian Hoehl1, Christiane Pallas1, Niko Kohmer1, Timo Wolf2,3, Holger F Rabenau1, Victor M Corman4,5, Christian Drosten4,5, Maria J G T Vehreschild2,3, Udo Goetsch6, Rene Gottschalk6, Sandra Ciesek1,5,7.   

Abstract

Whether monoclonal antibodies are able to neutralise SARS-CoV-2 variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab efficiently neutralise authentic SARS-CoV-2 including variant B.1.1.7 (Alpha) but variants B.1.351 (Beta) and P.2 (Zeta) were resistant against bamlanivimab and partially to casirivimab.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; bamlanivimab; casirivimab; corona virus; imdevinab; monoclonal antibodies

Year:  2021        PMID: 34223909     DOI: 10.1093/infdis/jiab355

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination.

Authors:  Aaron Richterman; Eric A Meyerowitz; Muge Cevik
Journal:  Open Forum Infect Dis       Date:  2021-05-19       Impact factor: 3.835

Review 2.  Two Years into the COVID-19 Pandemic: Lessons Learned.

Authors:  Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Renata Pessôa Germano Mendes; Klarissa Miranda Guarines; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Jurandy Júnior Ferraz de Magalhães; Justin R J Vigar; Abelardo Silva-Júnior; Alain Kohl; Keith Pardee; Lindomar Pena
Journal:  ACS Infect Dis       Date:  2022-08-08       Impact factor: 5.578

Review 3.  SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Authors:  Nina Kreuzberger; Caroline Hirsch; Khai Li Chai; Eve Tomlinson; Zahra Khosravi; Maria Popp; Miriam Neidhardt; Vanessa Piechotta; Susanne Salomon; Sarah J Valk; Ina Monsef; Christoph Schmaderer; Erica M Wood; Cynthia So-Osman; David J Roberts; Zoe McQuilten; Lise J Estcourt; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2021-09-02

4.  The mRNA vaccine revolution is the dividend from decades of basic science research.

Authors:  Arturo Casadevall
Journal:  J Clin Invest       Date:  2021-09-24       Impact factor: 19.456

5.  Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.

Authors:  Jiahua Cui; Jinping Jia
Journal:  Eur J Med Chem       Date:  2021-08-18       Impact factor: 6.514

Review 6.  SARS-CoV-2 Variants: Mutations and Effective Changes.

Authors:  Gene Park; Byeong Hee Hwang
Journal:  Biotechnol Bioprocess Eng       Date:  2021-12-28       Impact factor: 2.836

7.  Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern.

Authors:  Ahmed Babiker; Katherine Immergluck; Samuel D Stampfer; Anuradha Rao; Leda Bassit; Max Su; Vi Nguyen; Victoria Stittleburg; Jessica M Ingersoll; Heath L Bradley; Maud Mavigner; Nils Schoof; Colleen S Kraft; Ann Chahroudi; Raymond F Schinazi; Greg S Martin; Anne Piantadosi; Wilbur A Lam; Jesse J Waggoner
Journal:  J Clin Microbiol       Date:  2021-08-25       Impact factor: 5.948

8.  Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.

Authors:  Bjoern Jensen; Nadine Luebke; Torsten Feldt; Verena Keitel; Timo Brandenburger; Detlef Kindgen-Milles; Matthias Lutterbeck; Noemi F Freise; David Schoeler; Rainer Haas; Alexander Dilthey; Ortwin Adams; Andreas Walker; Joerg Timm; Tom Luedde
Journal:  Lancet Reg Health Eur       Date:  2021-07-14

9.  Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.

Authors:  Julian U G Wagner; Denisa Bojkova; Jindrich Cinatl; Stefanie Dimmeler; Mariana Shumliakivska; Guillermo Luxán; Luka Nicin; Galip S Aslan; Hendrik Milting; Joshua D Kandler; Andreas Dendorfer; Andreas W Heumueller; Ingrid Fleming; Sofia-Iris Bibli; Tobias Jakobi; Christoph Dieterich; Andreas M Zeiher; Sandra Ciesek
Journal:  Basic Res Cardiol       Date:  2021-07-05       Impact factor: 17.165

Review 10.  COVID-19: Myths and Reality.

Authors:  Larisa V Kordyukova; Andrey V Shanko
Journal:  Biochemistry (Mosc)       Date:  2021-07       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.